Innovations In Clinical Neuroscience

HOTTOP Multiple Sclerosis DEC 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 25 of 27

26 Hot Topics in Multiple Sclerosis [December 2017] micro-RNA molecules that allowed them to differentiate between the two types of multiple sclerosis. * More information ASTHMA DRUG MIGHT SLOW BRAIN DAMAGE IN MULTIPLE SCLEROSIS PATIENTS A small study on an asthma drug approved in Japan found that the drug was able to slow brain atrophy for patients with multiple sclerosis (MS). The research suggests that while the drug was originally meant to "calm" the immune cells that lead to asthma, it can have the same effect on the immune cells that are related to MS. * More information CONCUSSIONS IN TEENAGERS TIED TO MULTIPLE SCLEROSIS RISK A large-scale study found that teenagers who suffered concussions were more likely to eventually develop multiple sclerosis. This risk increases even more for people who have suffered multiple concussions in their lifetime. * More information COULD SHE DEVELOP A BREAKTHROUGH TREATMENT FOR MULTIPLE SCLEROSIS? Neuroscientist Dr. Su Metcalfe is developing nanoparticles to treat multiple sclerosis. The idea of the treatment would reprogram the body's immune system and "deliver a growth factor, LIF, directly and specifically to sites of nerve damage, which keeps the immune system from attacking myelin." * More information HEALTHY DIET LINKED TO REDUCED MULTIPLE SCLEROSIS DISABILIT Y Research published in Neurology found that, among the 6,989 patients with multiple sclerosis (MS) who participated in the study, people who ate a diet full of fruits, vegetables, and whole grains were more likely to experience reduced MS symptoms. The diet also included fewer red and processed meats, as well as less sugar from desserts and beverages. * More information NEW FORECAST PREDIC TS THERE WILL BE SIX MILLION PEOPLE WITH ALZHEIMER'S DISEASE OR COGNITIVE IMPAIRMENT Research funded by the National Institutes of Health estimated that this number will reach 15 million by 2060. The full research was published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. * More information ALL-ISLAND MULTIPLE SCLEROSIS RESEARCH STUDY LAUNCHED Genomics Medicine Ireland will be undergoing a five-year study using patients with multiple sclerosis (MS) from three major hospitals in Ireland. The study, which is the largest MS study in Ireland to date, will likely expand to additional hospitals as the research process continues. * More information TAURINE LENDS HAND TO REPAIR CELLS DAMAGED IN MULTIPLE SCLEROSIS Researchers at The Scripps Research Institute (TSRI) found that taurine, which is naturally produced by human cells, could aid therapies for the treatment of multiple sclerosis (MS). Taurine induces remyelination, which helps repair damaged cells in patients with MS. * More information NATIONAL SURVEY REVEALS MA JORIT Y OF WOMEN NEWLY DIAGNOSED WITH MULTIPLE SCLEROSIS HAVE CONCERNS THEY AREN'T DISCUSSING WITH THEIR HEALTHCARE TEAM Women newly diagnosed with multiple sclerosis have significant concerns about how the disease will affect certain aspects of their lives, but a survey asking about personal relationships, reproductive issues, and employment concerns shows 98 percent felt many of these concerns were not addressed by their healthcare team when first diagnosed. * More information INCREASED EPILEPSY RISK IDENTIFIED IN MULTIPLE SCLEROSIS An article published in Neurology found a direct relationship between multiple sclerosis (MS) and the risk for epilepsy. Of the 14,545 patients with MS included in the study, 3.5 percent of patients had epilepsy, compared to only 1.4 percent of the control group. * More information UNIVERSIT Y OF ILLINOIS RESEARCHERS WIN $300,000 FALK AWARD TO IMPROVE MS DRUG DELIVERY The researchers aim to "transform naturally occurring small vesicles released by several cell types into drug targeted delivery vehicles." They plan to initially test their plan on mice before expanding with their research, which will use microRNAs to increase myelin production. * More information N E W S & T R E N D S

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - HOTTOP Multiple Sclerosis DEC 2017